Anti-Human CD192 Recombinant Antibody
-
产品编号
YR1384
-
别名
科研级 Plozalizumab ( 洛扎利珠单抗 ), Anti-CD192 Recombinant Antibody, Research Grade Plozalizumab
-
规格
- 1mg
- 5mg
| Catalog Number | YR1384 |
| Alias | 科研级 Plozalizumab ( 洛扎利珠单抗 ), Anti-CD192 Recombinant Antibody, Research Grade Plozalizumab |
| Size | 1mg, 5mg |
| Molecular Name | Plozalizumab |
| CAS Number | 1610761-46-0 |
| Target | CD192[Homo sapiens] |
| Antibody Isotype | IgG1 Kappa |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Plozalizumab (INN, hu1D9) is a humanized monoclonal antibody designed for the treatment of diabetic nephropathy and arteriovenous graft patency. This drug was developed by Takeda Pharmaceuticals International Co. |
| Application | ELISA, IHC, IF, IP, FCM, Inhib |
| Remarks | This product is for research use only. |
0